Molecular Partners AG (XSWX:MOLN)
CHF 3.395 0.09 (2.72%) Market Cap: 111.59 Mil Enterprise Value: -59.19 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 53/100

Molecular Partners AG - Special Call Transcript

Dec 17, 2020 / 02:00PM GMT
Release Date Price: CHF22.5 (+1.35%)
Seth D. Lewis
Molecular Partners AG - SVP of IR, Communications & Strategy

Good morning, everyone, and welcome to the Molecular Partners' 2020 Research and Development Day, Unlock and Expand: Custom-Built Biology for Patients. My name is Seth Lewis, Senior Vice President of Investor Relations and Communications. And we're pleased to have you here joining us today as members of senior management and invited guests will provide an update not only on the clinical and research progress of the past year but also the outlook from 2021 and beyond.

As a matter of housekeeping, I would like to inform you all that management will be making certain forward-looking statements today and that this has been broadcast on December 17, 2020. Please refer to our website for our latest corporate updates, should anything have changed since the date of this recording. We also issued a press release this morning, where additional updates were provided, many of which will be covered in today's discussion, but please refer to the press release that was issued today as well.

Pleased to introduce multiple

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot